12 results
Search Results
2. Multisystem inflammatory syndrome in children: A review.
- Author
-
Benvenuto S, Avcin T, and Taddio A
- Subjects
- Humans, Child, Systemic Inflammatory Response Syndrome diagnosis, Systemic Inflammatory Response Syndrome therapy, COVID-19 complications, COVID-19 epidemiology
- Abstract
Aim: To comprehensively review the literature on multisystem inflammatory syndrome in children (MIS-C)., Methods: Narrative review of relevant studies published between April 2020 and January 2024., Results: MIS-C is a SARS-CoV-2-related hyperinflammatory syndrome developing 2-6 weeks after COVID-19 in genetically susceptible individuals. Persisting fever, mucocutaneous manifestations, GI and cardiac involvement, together with lymphopenia and elevated inflammatory and cardiac markers are the main clinical features. It is believed to recognise some pathogenetic and clinical overlap with Kawasaki disease. New case definitions have been proposed after an assessment of the diagnostic performance of existing criteria; epidemiological criterion is however progressively losing its usefulness as the pandemic turns into an endemic and in the areas with the highest rates of COVID-19 vaccination. Current guidelines recommend both intravenous immunoglobulin and glucocorticoids in the first-line immunomodulatory treatment, mainly based on comparative retrospective cohorts; the actual role of biologics remains to be adequately established. Strict follow-up is mandatory, especially for those with severe cardiac involvement, as longitudinal studies evaluate the long-term evolution of cardiac damage., Conclusion: In this paper, we review the epidemiological, pathogenetic, clinical and prognostic features of MIS-C, and outline the main questions which still remain unanswered after more than 3 years of research., (© 2024 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
3. National data showed an increased prevalence of overweight and obesity among four-year-old Swedish children during the first year of COVID-19.
- Author
-
Miregård J, Nowicka P, and Nylander C
- Subjects
- Male, Female, Humans, Child, Preschool, Sweden epidemiology, Prevalence, Pandemics, Obesity epidemiology, Body Mass Index, Overweight epidemiology, COVID-19 epidemiology
- Abstract
Aim: This paper summarised national data on the prevalence of overweight and obesity among 4-year-old children in Sweden in 2020, the first year of the COVID-19 pandemic. It compares this with data from 2018. Differences between regions and sex were identified., Methods: Comparative data from Swedish Child Health Services were available for 18/21 regions. Chi-square tests were used to compare data from 2018 and 2020 and to examine differences between the sexes. Sex and year were examined through interaction tests., Results: In 2020, 13.3% of the 100 001 children had overweight or obesity: 15.1% of the girls and 11.6% of the boys (p < 0.001). In 2018, 11.4% of the 105 445 children had overweight or obesity: 13.2% of the girls and 9.4% of the boys. This was an overall increase of 16.6% (p = 0.000) in the national Swedish data from 2018 to 2020. The increase between the years was greater for obesity (31.8%, p = 0.000) than for overweight (13.3%, p = 0.000)., Conclusion: The prevalence of overweight and obesity among 4-year-olds in Sweden increased during the COVID-19 pandemic and needs to be addressed. The prevalence needs to be followed as part of prevention programmes and to evaluate health interventions., (© 2023 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.)
- Published
- 2023
- Full Text
- View/download PDF
4. How Sweden approached the COVID-19 pandemic: Summary and commentary on the National Commission Inquiry.
- Author
-
Ludvigsson JF
- Subjects
- Humans, Aged, Pandemics, Sweden epidemiology, Europe epidemiology, COVID-19 epidemiology
- Abstract
Aim: Sweden initially chose a different disease prevention and control path during the pandemic than many other European countries. In June 2020, the Swedish Government established a National Commission to examine the management of COVID-19 in Sweden. This paper summarises, and discusses, its findings., Methods: Three reports published by the Commission were analysed. The first focused on the care of older people during the pandemic. The second examined disease and infection transmission and control and health care and public health. The third updated the first two reports and also covered economic aspects, crisis management and public communication., Results: By 25 February 2022, when the final report was published, 15 800 individuals, 1.5 per 1000 Swedish inhabitants, had died after COVID-19. The death rates were high in spring 2020, but overall excess mortality in 2020-2021 was +0.79%, which was lower than in many other European countries. The Commission suggested that the voluntary measures that were adopted were appropriate and maintained Swedes' personal freedom during the pandemic. However, more extensive and earlier measures should have been taken, especially during the first wave., Conclusion: The Swedish COVID-19 Commission felt that earlier and more extensive pandemic action should have been taken, particularly during the first wave., (© 2022 The Author. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.)
- Published
- 2023
- Full Text
- View/download PDF
5. Systematic review of health and disease in Ukrainian children highlights poor child health and challenges for those treating refugees.
- Author
-
Ludvigsson JF and Loboda A
- Subjects
- COVID-19 Vaccines, Child, Child Health, Female, Humans, Infant, Newborn, COVID-19, Pediatric Obesity, Refugees
- Abstract
Aim: Millions of Ukrainian children have been internally displaced or fled to other countries because of the Russian war. This systematic review focused on their health needs and future challenges for clinicians., Methods: A systematic literature search of the Medline, Embase and MedRxiv databases from 1 January 2010 to 31 March 2022 identified 1628 papers on the health of Ukrainian children and 112 were relevant to this review., Results: In 2019, under-5 mortality was 8 per 1000 live births in Ukraine. Underweight and adverse childhood experiences, including child abuse, were frequent compared to other European countries, while childhood obesity seemed less common. Alcohol consumption was common in women of reproductive age, including during pregnancy, risking foetal alcohol syndrome. Neonatal screening programmes provided low coverage. Vaccine hesitancy was common and vaccination rates were low. Other concerns were measles, HIV, antibiotic resistance and multi-resistant tuberculosis. Many children are expected to suffer from psychological and physical trauma due to the war. Other healthcare challenges include low COVID-19 vaccination rates and a preference for secondary and tertiary care, rather than primary care. Many people cannot afford medication., Conclusion: Ukrainian children often have poor health and host countries need to be aware of their needs., (© 2022 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.)
- Published
- 2022
- Full Text
- View/download PDF
6. Convulsions in children with COVID-19 during the Omicron wave.
- Author
-
Ludvigsson JF
- Subjects
- Adolescent, Child, Fever, Humans, Infant, Male, SARS-CoV-2, COVID-19 complications, Seizures, Febrile
- Abstract
Aim: Most children with COVID-19 have mild symptoms, but data on the Omicron variant are rare. This paper describes unexpected cases with convulsions during 1 week in January 2022., Methods: Four children with COVID-19 were admitted with convulsions to the paediatric department in Örebro, Sweden, when Omicron accounted for more than 98% of the country's COVID-19 cases. Three children tested positive for the virus, and one had clinical COVID-19. I was able to contact the parents of three boys, who gave consent for these case studies., Results: Two boys aged 3 and 21 months tested positive for the virus and a 14-year-old boy tested negative, but had a cold and family members who had tested positive. The teenager had a history of urinary tract infections, but the younger boys had no earlier comorbidities. None had a history of epilepsy or febrile convulsions. The younger children had a fever and the teenager had upper respiratory symptoms. The 3-month-old child had repeated convulsions for several hours, the 21-month-old had continuous convulsions for 15-20 min, and the teenager had a convulsion for 30-60 s, followed by uncharacteristic aggression., Conclusion: Convulsions may be a sign of the Omicron variant in children with COVID-19., (© 2022 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.)
- Published
- 2022
- Full Text
- View/download PDF
7. How compassionate use enabled Israel to deliver the Pfizer-BioNTech COVID-19 vaccination to vulnerable children aged 12-15 years before regulatory approval.
- Author
-
Stein M, Grossman Z, Brosh-Nissimov T, Gottesman BS, Shahar A, Wechsler E, Matz E, Cohen O, Alroy-Preis S, and Anis E
- Subjects
- Adolescent, Child, Child, Preschool, Compassionate Use Trials, Humans, Israel, SARS-CoV-2, Systemic Inflammatory Response Syndrome, United States, Vaccination, COVID-19 complications, COVID-19 prevention & control, COVID-19 Vaccines adverse effects
- Abstract
Aim: This paper describes the emergency, compassionate use of the COVID-19 vaccination for high-risk adolescents aged 12-15 years prior to approval by the American Food and Drugs Administration in May 2021. The target audience had underlying health conditions associated with severe disease and multisystem inflammatory syndrome in children (MIS-C) or severely immunosuppressed household members., Methods: An orderly approval system was established in Israel for adolescents aged 12-15 years, based on a professional position paper and compassionate treatment regulations. From 12 February 2021, eligible adolescents were referred to the Israeli Ministry of Health for permission to vaccinate, via four health maintenance organisations. Data were collected about adverse events after vaccinations and the incidence of any cases of COVID-19., Results: By 15 March 2021, the vaccine had been approved for 607 adolescents: 333 had received one dose, and 92 had received two doses. The median age was 14.6 years, and the major indication was obesity. Only one child tested positive for the virus, 4 days after vaccination, and no adverse effects were recorded., Conclusion: The emergency use of COVID-19 vaccination for 333 adolescents aged 12-15, 92 of them with 2 doses, based on a position paper and compassionate treatment regulations, did not result in any adverse effects. Since 27 July 2021, the same process was further applied in Israel among younger children, aged 5-11, preceding formal release of the clinical trial., (© 2021 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
8. Providing children with COVID-19 vaccinations is challenging due to lack of data and wide-ranging parental acceptance.
- Author
-
She J, Liu L, and Liu W
- Subjects
- Adult, Child, Humans, Pandemics, Parents, SARS-CoV-2, Vaccination, COVID-19, COVID-19 Vaccines
- Abstract
Aim: Vaccines are vital to ending the COVID-19 pandemic and we reviewed the data on vaccinating children, and including them in clinical trials, as most of the activity has focused on adults., Methods: English and Chinese databases, including PubMed, Elsevier Scopus, Web of Science, CNKI and CQVIP were searched, along with websites such as the World Health Organization and the University of Oxford., Results: We identified 44 papers and 16 news items about vaccinating children against the virus, published from 10 February 2020 to 14 July 2021. Child vaccination has been slow and only a few countries have included children in Phase II or III clinical trials. The data on children were much more limited than on adults, but most children were asymptomatic or had mild symptoms and some deaths had been recorded. More clinical trials are needed to assess the safety and efficacy of vaccinating children, as higher vaccination levels can help to build up herd immunity. The percentage of parents willing to vaccinate their children against the virus ranged from 48.2% to 72.6%, with much lower rates for letting them participate in clinical trials., Conclusion: Vaccines should be offered to children as soon as their safety and efficacy are established., (© 2021 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
9. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19.
- Author
-
Ludvigsson JF
- Subjects
- Adolescent, Age Factors, COVID-19 diagnosis, COVID-19 epidemiology, Child, Female, Humans, Male, Symptom Assessment, Time Factors, COVID-19 complications
- Abstract
Aim: Persistent symptoms in adults after COVID-19 are emerging and the term long COVID is increasingly appearing in the literature. However, paediatric data are scarce., Methods: This paper contains a case report of five Swedish children and the long-term symptoms reported by their parents. It also includes a systematic literature review of the MEDLINE, EMBASE and Web of Science databases and the medRxiv/bioRxiv pre-print servers up to 2 November 2020., Results: The five children with potential long COVID had a median age of 12 years (range 9-15) and four were girls. They had symptoms for 6-8 months after their clinical diagnoses of COVID-19. None were hospitalised at diagnosis, but one was later admitted for peri-myocarditis. All five children had fatigue, dyspnoea, heart palpitations or chest pain, and four had headaches, difficulties concentrating, muscle weakness, dizziness and sore throats. Some had improved after 6-8 months, but they all suffered from fatigue and none had fully returned to school. The systematic review identified 179 publications and 19 of these were deemed relevant and read in detail. None contained any information on long COVID in children., Conclusion: Children may experience similar long COVID symptoms to adults and females may be more affected., (© 2020 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.)
- Published
- 2021
- Full Text
- View/download PDF
10. The first eight months of Sweden's COVID-19 strategy and the key actions and actors that were involved.
- Author
-
Ludvigsson JF
- Subjects
- COVID-19 epidemiology, COVID-19 transmission, Humans, Pandemics, Personal Protective Equipment, Sweden epidemiology, COVID-19 prevention & control, Health Policy, Physical Distancing
- Abstract
Aim: COVID-19 has affected millions of people worldwide. This paper reviews the Swedish pandemic response., Methods: A narrative review was carried out and a timeline constructed., Results: By September 1, 2020, 0.8% of Swedish residents had tested positive for the virus and 0.06% of the population had died, which was higher than neighbouring Nordic countries, but lower than some European countries with general lockdowns. The main actors were the Public Health Agency, the National Board of Health and Welfare, the Civil Contingencies Agency and the Government. County councils and regions implemented policies, in conjunction with the Department of Education and county administrative boards. Sweden's response was less invasive than many other countries, with no general lockdown. It focused on mitigation: slowing, but not stopping, the pandemic. Physical distancing was recommended in public spaces, but mandatory in bars, restaurants and at events. Visits to nursing facilities were banned. Kindergartens and schools for children up to 16 stayed open, but closed for older children for three months. There were no enforced quarantines for infected households or geographical regions, and facemasks were not recommended outside health care., Conclusion: Sweden chose a different pandemic strategy to its peer nations. This paper examines the first eight months., (© 2020 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.)
- Published
- 2020
- Full Text
- View/download PDF
11. An overview of smell and taste problems in paediatric COVID-19 patients.
- Author
-
Erdede O, Sarı E, Uygur Külcü N, Uyur Yalçın E, and Sezer Yamanel RG
- Subjects
- Child, Female, Humans, Turkey epidemiology, COVID-19 epidemiology, Olfaction Disorders virology, Taste Disorders virology
- Abstract
At the start of the COVID-19 pandemic in March 2020, fever and respiratory symptoms were the indications for virus testing in our hospital. As data have continued to accumulate worldwide, gastrointestinal, neurological, cardiovascular, cutaneous and ocular symptoms have been reported for confirmed COVID-19 cases. There have been few case reports on problems with taste and smell in paediatric COVID-19. However, new symptoms can provide diagnostic and testing criteria for patients with no other clinical presentation, especially in older children. CONCLUSION: This paper looks at the taste and smell problems reported in paediatric patients and shares insights from our hospital., (©2020 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
12. Novel coronavirus infection (COVID-19) in children younger than one year: A systematic review of symptoms, management and outcomes.
- Author
-
Raba AA, Abobaker A, Elgenaidi IS, and Daoud A
- Subjects
- COVID-19 blood, COVID-19 therapy, Humans, Infant, Infant, Newborn, COVID-19 epidemiology
- Abstract
Aim: The aim of this systematic review was to evaluate the clinical characteristics of COVID-19 in neonates and children under one year of age., Methods: A systematic literature review of the MEDLINE, PubMed, CINAHL, Embase and EBSCO databases was carried out for studies from January 1, 2020, to April 7, 2020. We included all papers that addressed clinical manifestations, laboratory results, imaging findings and outcomes in infants and neonates., Results: Our search identified 77 peer-reviewed papers, and 18 papers covering 160 infants were reviewed. One paper was from Vietnam, and the other 17 were from China: eight were cross-sectional studies, eight were case reports, one was a case series, and one was a prospective cohort study. The most common clinical symptoms were fever (54%) and cough (33%). Most infants were treated symptomatically, with frequent use of various empirical medications. Infants and neonates tended to have more severe COVID-19 disease than older children: 11 (7%) were admitted to intensive care and one infant died. The mortality rate was 0.006%, with favourable outcomes in most cases., Conclusion: Infants and neonates were more vulnerable to more severe COVID-19 disease than older children, but morbidity and mortality were low., (© 2020 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.